insights_auto
Why is GENB down 8,12%?
Dive Deeperchevron_right
GENB:NASDAQ
Generate Biomedicines Inc
13,80 $
arrow_downward
-8,12%(-1,22) 1D
14,19 $
arrow_upward
+2,83% (+0,39)todayPre-market
Closed: 1 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GENB...
Open
14,79 $
High
14,99 $
Low
13,76 $
Mkt. cap
1,77 մլրդ
Avg. vol.
1,51 մլն
Volume
3,79 հզր
52-wk high
22,67 $
52-wk low
11,00 $
No. of employees
312
Open
14,79 $
High
14,99 $
Low
13,76 $
Mkt. cap
1,77 մլրդ
Avg. vol.
1,51 մլն
Volume
3,79 հզր
52-wk high
22,67 $
52-wk low
11,00 $
No. of employees
312
News stories
From web sources and news partners
CryptoRank
·
6 րոպե առաջ
OpenWorld Begins Nasdaq Trading As VerifyMe Deal Creates Public Tokenization Company
Inc.com
·
21 րոպե առաջ
More Than Half the Market Is Down 20 Percent. This 1 Indicator Could Decide What Happens Next
Seeking Alpha
·
1 ժամ առաջ
Inside The September 2026 S&P 500 Momentum Index Reconstitution
Investor's Business Daily
·
40 րոպե առաջ
Futures Await Jobs, Tesla; Micron Flashes Buy Signal
Profile
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
About Generate Biomedicines Inc
CEO-
Employees312
Founded2018
HeadquartersՍոմերվիլ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitegeneratebiomedicines.com